0 items USD 0.00Search
- Did you mean
- chronic lymphoma leukemia
Your search for "Chronic lymphocytic leukemia" gave back 5130 results.
Chronic myeloid leukemia (CML) is also known as chronic myelogenous leukemia. It's a type of cancer that starts in certain blood-forming cells...
Catalog:
MRRPB5
May 2023
Price: USD 4,900.00
Chronic myeloid leukemia (CML) is also known as chronic myelogenous leukemia. It's a type of cancer that starts in certain blood-forming cells...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Chronic myeloid leukaemia (CML) is a type cancer that affects the blood and bone marrow. The “Chronic Myeloid Leukemia (CML) Treatment Industry...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Chronic myeloid leukemia (CML) is a type of cancer that starts in certain blood-forming cells of the bone marrow. It most commonly occurs in the...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Daunorubicin is mainly used for acute lymphocytic or myelogenous leukemia resistant to common anti-tumor drugs, but the remission period is short, so...
Catalog:
LPI
March 2023
Price: USD 3,660.00
Publisher' newest research report, the “Chronic Eosinophilic Leukemia (CEL) Drugs Industry Forecast” looks at past sales and reviews total world...
Catalog:
LPI
January 2023
Price: USD 3,660.00
As the global economy recovers in 2021 and the supply of the industrial chain improves, the Chronic Eosinophilic Leukemia (CEL) Drugs market will...
Catalog:
Arsta
May 2022
Price: USD 3,360.00
Acalabrutinib (ACP-196) is an orally active, irreversible, and highly selective second-generation BTK inhibitor. Acalabrutinib binds covalently to...
Catalog:
LPI
February 2023
Price: USD 3,660.00
As the global economy recovers in 2021 and the supply of the industrial chain improves, the Chronic Eosinophilic Leukemia (CEL) Drugs market will...
Catalog:
Arsta
May 2022
Price: USD 3,360.00
Chronic myeloid leukemia (CML) is also known as chronic myelogenous leukemia. It's a type of cancer that starts in certain blood-forming cells...
Catalog:
MRRPB5
February 2023
Price: USD 2,900.00
Chronic myeloid leukaemia (CML) is a type cancer that affects the blood and bone marrow. Highlights The global Chronic Myeloid Leukemia (CML)...
Catalog:
MRRPB5
February 2023
Price: USD 2,900.00
Highlights The global Chronic Eosinophilic Leukemia (CEL) Drugs market was valued at US$ million in 2022 and is anticipated to reach US$ million by...
Catalog:
MRRPB5
January 2023
Price: USD 2,900.00
The global Hematologic Malignancies Treatment market size was valued at US$ 52290 million in 2023. With growing demand in downstream market, the...
Catalog:
LPI
January 2024
Price: USD 3,660.00
Hematological malignancy, also known as hematological disease, is a type of cancer impacting bone marrow, blood, and lymph nodes. Different sorts of...
Catalog:
GIR
April 2023
Price: USD 3,480.00
Ofatumumab is a fully human monoclonal antibody to CD20, which appears to inhibit early-stage B lymphocyte activation. Under the brand name Arzerra,...
Catalog:
LPI
February 2023
Price: USD 3,660.00
